<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862512</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1560</article-id><article-id pub-id-type="other">EPV0972</article-id><article-id pub-id-type="pii">S0924933824015608</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Psychometric assessment of patients with treatment-resistant schizophrenia</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kaleda</surname><given-names>V.</given-names></name><xref rid="aff3398" ref-type="aff"/><xref rid="cor1409" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tikhonov</surname><given-names>D.</given-names></name><xref rid="aff3398" ref-type="aff"/></contrib></contrib-group><aff id="aff3398"><institution>Mental Health Research Centre</institution>, <city>Moscow</city>, <country>
Russian Federation</country></aff><author-notes><corresp id="cor1409"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1535">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S749</fpage><lpage>S750</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824015608a.pdf"/><abstract><sec id="sec8470"><title>Introduction</title><p>Treatment-resistant schizophrenia (TRS) is one of the most pressing issues in the field of treatment and research of psychotic disorders. The pronounced&#x000a0;decline in social and professional functioning in this group of patients&#x000a0;as well as&#x000a0;high costs of therapy determine high interest in TRS. This is a part of an ongoing study on the clinical and biological features of TRS.</p></sec><sec id="sec8471"><title>Objectives</title><p>The aim&#x000a0;of this study is to identify the leading symptoms in patients with&#x000a0;TRS.</p></sec><sec id="sec8472"><title>Methods</title><p>Using the Personal and Social Performance Scale (PSP), Positive and Negative Syndrome Scale (PANSS) and Calgary Depression Scale for schizophrenia (CDSS), 30 male patients (age 28.99 &#x000b1; 8.08 years) diagnosed with&#x000a0;paranoid schizophrenia (F20.0) were examined. All patients had&#x000a0;persistent productive symptoms and&#x000a0;met the criteria for TRS. The average daily doses of antipsychotics in chlorpromazine equivalent were 1382.07 &#x000b1; 897.15 mg/day. The average age of onset of the disease was 19.52 &#x000b1; 5.97 years, the average disease was 9.47 &#x000b1; 7.61 years.</p></sec><sec id="sec8473"><title>Results</title><p>The average scores were: on the PSP scale: 46.05 &#x000b1; 9.17, on the CDSS scale 8.10 &#x000b1; 4.53, on the PANSS positive symptoms subscale - 21.52 &#x000b1; 4.24, on the PANSS negative symptoms subscale - 24.67 &#x000b1; 4.42, on the general psychopathology subscale&#x000a0;PANSS &#x02013; 45.62 &#x000b1; 6.11 . Positive symptoms were represented mainly by delusions (P1, 4.14 &#x000b1; 0.85 points) and hallucinations (P3, 4.10 &#x000b1; 1.76 points). Blunted affect (N1, 4.29 &#x000b1; 0.56 points) and emotional withdrawal (N2, 3.67 &#x000b1; 0.73 points) predominated among negative symptoms, while the least prominent negative symptom was poor rapport&#x000a0;(N3, 3.24 &#x000b1; 0.94). The most pronounced general psychopathology symptoms were depression (G6, 4.00 &#x000b1; 1.10 ) and lack of judgment and insight (G12, 4.05 &#x000b1; 0.92). The total score on the PANSS was 91.81 &#x000b1; 12.40.</p></sec><sec id="sec8474"><title>Conclusions</title><p>The CDSS score indicates a high incidence of depressive symptoms in patients with TRS. A low PSP score reflects poor social functioning. The most common symptoms&#x000a0;according to the PANSS are delusions, hallucinations, blunted affect, emotional withdrawal, depression and lack of judgment and insight.</p></sec><sec id="sec8475"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>